Screener
SIGA Technologies SIGA Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by SIGA Technologies in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: SIGA Technologies’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:46 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001437749-26-026314
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Product sales and supportive services | $37,870,335 | $79,124,860 | $41,408,212 | $84,946,107 |
| Research and development | 3,131,918 | 1,995,144 | 5,836,622 | 3,214,711 |
| Total revenues | 41,002,253 | 81,120,004 | 47,244,834 | 88,160,818 |
| Less: | ||||
| Cost of sales and supportive services | 17,561,185 | 25,554,462 | 20,502,069 | 25,712,200 |
| Employee expenses | 4,554,433 | 4,425,977 | 9,052,509 | 8,596,897 |
| R&D vendor expenses | 1,789,690 | 1,798,531 | 2,974,356 | 2,719,991 |
Item 1 - Condensed Consolidated Financial Statements
FAQ
- What is SIGA Technologies's business segments — revenue?
- SIGA Technologies (SIGA) reported business segments — revenue of $41M in Q2 2026.
- What does business segments — revenue mean?
- This represents the total gross revenue generated by the company's primary business operations, primarily driven by the sale of antiviral products like TPOXX. It serves as the top-line indicator of market demand and commercial success within the health security sector. Monitoring this metric helps investors assess the company's ability to secure government contracts and commercial sales.
Ask your AI about SIGA Technologies's business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude